- Home
- FLWS vs RIGL Comparison
FLWS vs RIGL Comparison
Compare FLWS & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLWS
- RIGL
- Stock Information
- Founded
- FLWS 1976
- RIGL 1996
- Country
- FLWS United States
- RIGL United States
- Employees
- FLWS N/A
- RIGL N/A
- Industry
- FLWS Other Specialty Stores
- RIGL Biotechnology: Pharmaceutical Preparations
- Sector
- FLWS Consumer Discretionary
- RIGL Health Care
- Exchange
- FLWS Nasdaq
- RIGL Nasdaq
- Market Cap
- FLWS 347.1M
- RIGL 335.5M
- IPO Year
- FLWS 1999
- RIGL 2000
- Fundamental
- Price
- FLWS $5.60
- RIGL $38.85
- Analyst Decision
- FLWS Hold
- RIGL Buy
- Analyst Count
- FLWS 1
- RIGL 5
- Target Price
- FLWS $7.50
- RIGL $38.20
- AVG Volume (30 Days)
- FLWS 349.6K
- RIGL 995.6K
- Earning Date
- FLWS 09-04-2025
- RIGL 08-05-2025
- Dividend Yield
- FLWS N/A
- RIGL N/A
- EPS Growth
- FLWS N/A
- RIGL N/A
- EPS
- FLWS N/A
- RIGL 5.43
- Revenue
- FLWS $1,709,948,000.00
- RIGL $267,921,000.00
- Revenue This Year
- FLWS N/A
- RIGL $59.93
- Revenue Next Year
- FLWS N/A
- RIGL N/A
- P/E Ratio
- FLWS N/A
- RIGL $7.15
- Revenue Growth
- FLWS N/A
- RIGL 105.62
- 52 Week Low
- FLWS $3.86
- RIGL $12.66
- 52 Week High
- FLWS $9.24
- RIGL $43.72
- Technical
- Relative Strength Index (RSI)
- FLWS 50.17
- RIGL 68.57
- Support Level
- FLWS $5.37
- RIGL $39.00
- Resistance Level
- FLWS $5.58
- RIGL $42.08
- Average True Range (ATR)
- FLWS 0.22
- RIGL 2.32
- MACD
- FLWS 0.00
- RIGL -0.37
- Stochastic Oscillator
- FLWS 63.49
- RIGL 53.26
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.